Targeting altered cancer methionine metabolism with recombinant methioninase (rMETase) overcomes partial gemcitabine-resistance and regresses a patient-derived orthotopic xenograft (PDOX) nude mouse model of pancreatic cancer.
about
Targeting altered cancer methionine metabolism with recombinant methioninase (rMETase) overcomes partial gemcitabine-resistance and regresses a patient-derived orthotopic xenograft (PDOX) nude mouse model of pancreatic cancer.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Targeting altered cancer methi ...... se model of pancreatic cancer.
@en
Targeting altered cancer methionine metabolism with recombinant methioninase
@nl
type
label
Targeting altered cancer methi ...... se model of pancreatic cancer.
@en
Targeting altered cancer methionine metabolism with recombinant methioninase
@nl
prefLabel
Targeting altered cancer methi ...... se model of pancreatic cancer.
@en
Targeting altered cancer methionine metabolism with recombinant methioninase
@nl
P2093
P2860
P1433
P1476
Targeting altered cancer methi ...... use model of pancreatic cancer
@en
P2093
Hiromichi Oshiro
Kei Kawaguchi
Kentaro Miyake
Masuyo Miyake
Michael Bouvet
Michiaki Unno
Qinghong Han
Robert M Hoffman
Shukuan Li
Takashi Higuchi
P2860
P304
P356
10.1080/15384101.2018.1445907
P577
2018-05-21T00:00:00Z